Limbaroc, Rhea .

HRN: 23-95-69  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2023
CEFTRIAXONE 1G (VIAL)
10/26/2023
11/02/2023
IV
1g
OD X 7
T/c Dengue Fever
Waiting Final Action 
10/27/2023
CEFTRIAXONE 1G (VIAL)
10/27/2023
11/03/2023
IV DRIP
1.5g
Q12
PCAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: